Abstract:Abstract BACKGROUND AND AIMS AKI occurs in ∼15% hospitalized patients and over 50% intensive care unit patients. However, effective therapeutic strategies for AKI are urgently needed. The exosomes derived from mesenchymal stem cells (MSC-exos) have achieved great focus as a cell-free therapy. As foremost metabolic organs, MSC-exos mainly collect in the liver and spleen. More attention should be considered how to induce more exosomes targeted to the injured kidney. In addition, the potential role of MSC-exos in injured kidney and the underlying mechanisms still need further research. METHOD Transmission electron microscopy, western blotting and nanoparticle tracking analysis were used to identify the properties of human umbilical cord mesenchymal stem cells (hucMSCs) derived exosomes. Kidney targeting peptide was chosen by the IVIS spectrum imaging system. Moreover, kidney targeting peptide (peptide-CGA) and CD63 targeting peptide were loaded to the MSC-exos by co-incubated (CGA-exos). Flow cytometry and immunofluorescence staining were utilized to confirm this. IVIS spectrum imaging system was used to assess MSC-exos distribution in vivo. RESULTS In vivo imaging showed that Peptide-CGA was efficiently homing to the ischemic kidney and predominantly accumulated in proximal tubules. Further Immunoprecipitation study showed that Peptide- CGA treatment group produced a specific stripe in silver staining compared with other groups. CGA-exos was successfully constructed. MSC-exos could alleviate murine ischemic kidney injury and reduced the renal tubules injury. Furthermore, in vivo imaging showed CGA-exos treatment group could attract more MSC-exos into the injured kidney, and its therapeutic effect was significantly better than that of the MSC-exos treatment group. without causing significant organ side effects. CONCLUSION Novel kidney targeting MSC-exos was constructed. It exhibited a preferential tendency to injured kidney and was localized to proximal tubules in AKI. We demonstrate that MSC-exos ameliorate ischemic AKI. But its further mechanisms need more insight. All in all, this highlights the potential of MSC-exos as a promising therapeutic strategy for AKI.

In Vivo Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondrial Function in Renal Ischemia-Reperfusion Injury.

<i>In Vivo</i> Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondria! Function in Renal Ischemia- Reperfusion Injury

In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration Via Aggregation-Induced Emission Luminogens

Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging

Regenerative Abilities of Mesenchymal Stem Cells Via Acting As an Ideal Vehicle for Subcellular Component Delivery in Acute Kidney Injury

Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Alleviate Renal Ischemic Reperfusion Injury and Enhance Angiogenesis in Rats.

In vivo two-photon microscopy reveals the contribution of Sox9+ cell to kidney regeneration in a mouse model with extracellular vesicle treatment

Augmented Efficacy of Exogenous Extracellular Vesicles Targeted to Injured Kidneys

In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T

Pan PPAR agonist stimulation of induced MSCs produces extracellular vesicles with enhanced renoprotective effect for acute kidney injury

Mesenchymal Stromal Cells Derived Extracellular Vesicles Ameliorate Acute Renal Ischemia Reperfusion Injury by Inhibition of Mitochondrial Fission Through Mir-30.

Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment

NK Cell Regulatory Property is Involved in the Protective Role of MSC-Derived Extracellular Vesicles in Renal Ischemic Reperfusion Injury

Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury

Protective effect of small extracellular vesicles (EVs) derived from ACE2‐modified human umbilical cord mesenchymal stem cells against renal ischemia–reperfusion injury

MO352: The Effect and Mechanism of Renal Targeted Delivery of MSC Exosomes in the Treatment of AKI

Application Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells in Renal Diseases

Arterially Transplanted Mesenchymal Stem Cells in a Mouse Reversible Unilateral Ureteral Obstruction Model: in Vivo Bioluminescence Imaging and Effects on Renal Fibrosis

In vivo Monitoring and Assessment of Exogenous Mesenchymal Stem Cell-Derived Exosomes in Mice with Ischemic Stroke by Molecular Imaging

Extracellular vesicles secreted from mesenchymal stem cells ameliorate renal ischemia reperfusion injury by delivering miR-100-5p targeting FKBP5/AKT axis

Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury